Acura Pharmaceuticals Cost of Goods Sold 2010-2021 | ACUR

Acura Pharmaceuticals cost of goods sold from 2010 to 2021. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Acura Pharmaceuticals Annual Cost of Goods Sold
(Millions of US $)
2021 $0
2020 $0
2019 $0
2018 $0
2017 $0
2016 $0
2015 $1
2014 $0
2013 $0
2012 $0
2011 $0
2010 $0
2009 $0
Acura Pharmaceuticals Quarterly Cost of Goods Sold
(Millions of US $)
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $0
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2014-06-30 $0
2014-03-31 $0
2013-12-31 $0
2013-09-30 $0
2013-06-30
2013-03-31
2012-12-31
2012-09-30
2012-06-30
2012-03-31
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.001B $0.000B
Halsey Drug Company, Inc. is engaged in the manufacture, sale and distribution of generic drugs. A generic drug is the chemical and therapeutic equivalent of a brand-name drug for which patent protection has expired. The company sells its generic drug products under its Halsey label and under private-label arrangements with drugstore chains and drug wholesalers.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.026B 6.88
Dr Reddy's Laboratories (RDY) India $12.104B 21.97
BridgeBio Pharma (BBIO) United States $6.401B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.859B 15.09
Bausch Health Cos (BHC) Canada $1.695B 1.25
Amphastar Pharmaceuticals (AMPH) United States $1.191B 7.93
Taysha Gene Therapies (TSHA) United States $0.629B 0.00
Personalis (PSNL) United States $0.438B 0.00
Assembly Biosciences (ASMB) United States $0.111B 0.00
Sol-Gel Technologies (SLGL) Israel $0.022B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00